InspireMD to Present at the 2017 Marcum Microcap Conference

InspireMD to Present at the 2017 Marcum Microcap Conference

ID: 547156

(firmenpresse) - TEL AVIV, ISRAEL -- (Marketwired) -- 06/09/17 -- InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it will be presenting at the on Friday, June 16th at 10:30 AM EST. James Barry, PhD, Chief Executive Officer of InspireMD will be presenting and meeting with investors.

The Marcum MicroCap Conference () is a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. More than 2000 investors and other participants from every segment of the microcap marketplace attend each year, including venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, and buy- and sell-side analysts, as well as senior executive teams from presenting companies and service providers to the microcap marketplace.

InspireMD seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

InspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard™), neurovascular, and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR and certain warrants are quoted on the NYSE MKT under the ticker symbol NSPR.WS.



InspireMD, Inc.
Craig Shore
Chief Financial Officer
Phone: 1-888-776-6804 FREE
Email:

Crescendo Communications, LLC
David Waldman
Phone: (212) 671-1021
Email:




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Canada House Increases Capability to Serve 1000 New Patients Monthly Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method
Bereitgestellt von Benutzer: Marketwired
Datum: 09.06.2017 - 11:00 Uhr
Sprache: Deutsch
News-ID 547156
Anzahl Zeichen: 0

contact information:
Town:

TEL AVIV, ISRAEL



Kategorie:

Healthcare



Diese Pressemitteilung wurde bisher 191 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"InspireMD to Present at the 2017 Marcum Microcap Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

InspireMD, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von InspireMD, Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z